Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
SCYNEXIS Inc. logo

SCYNEXIS Inc.

Sector: Healthcare   

Industry: Drug Manufacturers - Specialty & Generic

1.43
 
USD
  
0.04
  
(2.52%)
Optionable: Yes  Market Cap: 52 M  90-day average vol: 203,614

Previous close: 1.39  Open: 1.41  Bid: 1.4  Ask: 1.48
52 week range    
1.35   
   3.87
Peers   
GLMD / 
KMPH / 
CTLT / 
Last updated: Thursday 28th March 2024
36
MarketXLS Rank
60
Value
15
Technical
34
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

SCYX Income Statement

Annual
Invalid dateDec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccretionOnPreferredStock510000.0
AccruedPreferredStockDividends1 M
Amortization of intangibles200000.0700000.0
Basic EPS from continuing operations-10.4-23.3-15.8-9.4-2.8-9.6-5.15-1.25-1.47
Basic EPS total-10.4-26.8-2.8-9.6-5.15-1.25-1.47
Basic weighted shares outstanding566331.01 M2 M3 M4 M6 M11 M26 M43 M
BasicDiscontinuousOperations-10.4-3.5
Cost of sales-15 M
Depreciation-1 M-447000.0200000.0200000.0
Depreciation unreconciled755000.0100000.0400000.0428000.01 M1 M1 M2 M
DepreciationAndAmortization755000.0-447000.0100000.0400000.0428000.01 M1 M1 M2 M
Diluted EPS total-26.9-26.8-15.8-2.8-9.6-5.15-1.25-1.47
Diluted normalized net income/share-26.9-23.3-15.8-1.47
Diluted weighted shares outstanding414291.01 M2 M4 M6 M11 M26 M43 M
DilutedDiscontinuousOperations-26.9-3.5
GainOnSaleOfSecurity0.02 M2 M1 M1 M
GeneralAndAdministrativeExpense-1 M-247000.0-294000.09 M11 M15 M50 M63 M
Gross operating profit1 M257000.0257000.0257000.0257000.0121000.013 M5 M
ImpairmentOfCapitalAssets-51000.0
Income before tax-7 M-28 M-30 M-25 M-19 M-54 M-58 M-36 M-68 M
Income restructuring and M&A-1 M1 M
Income taxes-1 M-719000.0-24 M-7 M-883000.0-3 M-3 M-5 M
InsuranceAndClaims-165000.0
Interest income-48000.011000.0185000.0386000.0967000.0805000.0189000.024000.01 M
InterestExpenseNonOperating-11000.0351000.01 M2 M986000.01 M3 M5 M
MiscOtherSpecialCharges9 M-2 M3 M12 M-5 M-7 M28 M22 M
Net income from total operations-6 M-28 M-30 M-25 M-12 M-54 M-55 M-33 M-63 M
NetIncomeCommonStockholders-7 M-28 M-30 M-25 M-12 M-54 M-55 M-32 M-62 M
NetIncomeContinuousOperations-6 M-28 M-30 M-25 M-12 M-54 M-55 M-33 M-63 M
NetIncomeDiscontinuousOperations18 M7 M
NetNonOperatingInterestIncomeExpense-48000.011000.0-166000.0-1 M-659000.0-181000.0-992000.0-3 M-4 M
Normalized income-39 M-71 M
Operating income-15 M-28 M-28 M-27 M-30 M-50 M-51 M-61 M-86 M
Operating income before depreciation (EBITDA)-5 M-28 M-29 M-23 M-17 M-51 M-56 M-31 M-60 M
OperatingExpense-16 M-29 M-28 M-27 M31 M50 M51 M74 M91 M
Other income net-9 M-586000.02 M-3 M-12 M3 M5 M-29 M-24 M
OtherGandA-1 M-247000.0-294000.09 M11 M15 M50 M63 M
OtherImpairmentOfCapitalAssets-586000.0
OtherOperatingExpenses-664000.0-312000.0-628000.0
OtherWriteOff-163000.0
OtherunderPreferredStockDividend2 M
PreferredStockDividends2 M
RentAndLandingFees-952000.0-247000.0-294000.0
Research & development expense8 M16 M20 M18 M22 M38 M37 M24 M27 M
ResearchExpense8 M16 M20 M18 M22 M38 M37 M24 M27 M
RestructringAndMnAIncome-1 M1 M
Revenue per share755000.0100000.0400000.0428000.01 M1 M1 M2 M
SalariesAndWages-1 M-3 M-1 M-2 M-1 M-1 M-2 M-4 M-2 M
Selling Gen & administrative expense8 M12 M8 M8 M9 M11 M15 M50 M63 M
SellingAndMarketingExpense8 M12 M8 M8 M
SellingExpense8 M12 M8 M8 M
Special income/charges51000.01 M-1 M
Total Income available for interest expense (EBIT)-7 M-28 M-30 M-24 M-18 M-53 M-57 M-33 M-62 M
Total common shares outstanding851210.01 M3 M5 M5 M10 M21 M29 M33 M
Total net income-6 M-28 M-30 M-25 M-12 M-54 M-55 M-33 M-63 M
Total ordinary shares37 M37 M37 M37 M37 M37 M37 M37 M37 M
Total revenues1 M257000.0257000.0257000.0257000.0121000.013 M5 M
TotalExpenses-16 M-29 M-28 M-27 M31 M50 M51 M74 M91 M
TotalRevenue1 M257000.0257000.0257000.0257000.0121000.013 M5 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University